Skip to main content
. 2021 Feb 19;11(2):e043338. doi: 10.1136/bmjopen-2020-043338

Table 2.

Study characteristics

Publication(s) Year of publication Country No of participant (male:female) Setting CCDT Data collection Methodology Research question
Green et al18
Hamilton et al19
2013
2015
UK 23 (not reported) 175 practices from seven cancer networks selected to include areas of affluence and poverty and practices with non-white population ranging from 2% to 50%
UK
Risk Assessment Tool Telephone interviews
Topic guide
Framework To explore GPs experiences of incorporating the Risk Assessment Tools (RAT) for lung and bowel cancer into their clinical practice and in so doing, identify constraints and facilitators to the wider dissemination of the tools in primary care.
Dikomatis et al16 17 2012
2015
UK 23 (13:10) Diversity of practices located in deprived to affluent areas
UK
eRAT Telephone interviews
Topic guide
Framework Obtain views from general practitioners who piloted the electronic RATs (eRATs) for suspected lung or colorectal cancer. Whether GPs were able to integrate these tools into their everyday practice and identify facilitators and barriers to their more widespread use.
Chiang et al8 2015 Australia. 15 (10:5) Range of geographical location within Victoria
Australia
QCancer Interview after simulated cases
Semi-structured
Framework Explore the use of cancer risk tool (QCancer) in consultations and its potential impact on clinical decision making.
Moffat and Green4 2014 England, Scotland and Wales 28 (19:9) A mix of rural, suburban and urban areas and a range of affluent/eprived patient populations
UK
QCancer and Risk Assessment Tool Telephone interviews
semistructured
Framework Are clinical decision support tools acceptable to GPs and what are the barriers and facilitators to their integration into routine practice?
Akanuwe15 2018 England 5 (not reported) Lincolnshire (large rural county)
England
QCancer and Risk Assessment Tool Focus group
semistructured
Framework What do practitioners perceive as barriers and enablers (facilitators) to the implementation of cancer risk assessment tools?
Pannebakker et al20 2019 England 14 (5:9) Practices Central and Eastern Clinical Research Networks
England
7 Point Check List Face to face interview
semistructured
Framework To understand GP and patient perspectives on the implementation and usefulness of the eCDS.

CCDT, Clinical Cancer Decision Tool; eCDS, Electronic clinical decision support; GPs, general practitioners.